Yahoo Canada Web Search

Search results

  1. Recognising the urgent need to find a treatment for patients with triplet repeat expansion diseases, LoQus23 Therapeutics was co-founded in 2019 by David Reynolds, CEO and Caroline Benn, CSO when they were entrepreneurs in residence at the Dementia Discovery Fund.

    • caroline benn md1
    • caroline benn md2
    • caroline benn md3
    • caroline benn md4
  2. Articles 1–20. ‪LoQus23 Therapeutics‬ - ‪‪Cited by 3,208‬‬ - ‪Huntington's disease‬ - ‪neurodegeneration‬ - ‪molecular biology‬ - ‪drug discovery‬.

  3. Caroline Benn is the CSO of LoQus23 Therapeutics, Cambridge, UK. Caroline is a molecular and cellular neuroscientist with research expertise in Huntington's disease and drug discovery.

  4. A determinedly private person, Caroline Benn secured an independent academic status for her work to secure the aim of a basic entitlement of a good education for all young people while married to Tony Benn, one of the most prominent post-war socialists in Britain.

  5. Post-Doctorate. Executive (VP, SVP, CFO, CTO etc.) Primary. LoQus23 Therapeutics. Cambridge, United Kingdom. Other. Cambridge, United Kingdom. Caroline Benn. Overview.

  6. Since 1965 she has been the editor of Comprehensive Education and research officer of the national Campaign for Comprehensive Education. Among her publications is Half Way There, Report on the British Comprehensive School Reform, written with Brian Simon in 1970.

  7. People also ask

  8. This British Academy funded project (2014 - 2016) investigates the life & work of leading educational reformist Caroline Benn, wife of one of the most prominent postwar socialists in Britain, Tony Benn.

  1. Related searches

    caroline benn md -